Muscarinic acetylcholine receptors (mAChRs) play an important role in the tonic regulation of nociceptive transmission in the spinal cord. However, how mAChR subtypes contribute to the regulation of synaptic glycine release is unknown. To determine their role, glycinergic spontaneous inhibitory postsynaptic currents (sIPSCs) were recorded in lamina II neurons by using whole-cell recordings in spinal cord slices of wild-type (WT) and mAChR subtype knockout (KO) mice. In WT mice, the mAChR agonist oxotremorine-M dose dependently decreased the frequency of sIPSCs in most neurons but had variable effects in other neurons. In contrast, in M3-KO mice, oxotremorine-M consistently decreased the glycinergic sIPSC frequency in all neurons tested, and in M2/M4 double-KO mice, it always increased the sIPSC frequency. In M 2 /M 4 double-KO mice, the potentiating effect of oxotremorine-M was attenuated by higher concentrations in some neurons through activation of GABA B receptors. In pertussis toxin-treated WT mice, oxotremorine-M also consistently increased the sIPSC frequency. In M 2 -KO and M 4 -KO mice, the effect of oxotremorine-M on sIPSCs was divergent because of the opposing functions of the M 3 subtype and the M 2 and M 4 subtypes. This study demonstrates that stimulation of the M 2 and M 4 subtypes inhibits glycinergic inputs to spinal dorsal horn neurons of mice, whereas stimulation of the M 3 subtype potentiates synaptic glycine release. Furthermore, GABA B receptors are involved in the feedback regulation of glycinergic synaptic transmission in the spinal cord. This study revealed distinct functions of mAChR subtypes in controlling glycinergic input to spinal dorsal horn neurons.
Introduction
The cholinergic system and muscarinic acetylcholine receptors (mAChRs) are important for the regulation of nociceptive transmission in the spinal cord. In this regard, blocking of mAChRs in the spinal cord causes a large decrease in the nociceptive threshold (Zhuo and Gebhart, 1991) . Intrathecal administration of mAChR agonists or acetylcholinesterase inhibitors produces a potent analgesic effect in many species, including rats, mice, and humans (Iwamoto and Marion, 1993; Naguib and Yaksh, 1994; Hood et al., 1997; Ellis et al., 1999; Duttaroy et al., 2002; Chen and Pan, 2003) . Molecular cloning studies have revealed five molecularly distinct mAChRs (Caulfield, 1993; Wess, 1996) . The odd-numbered subtypes (M 1 , M 3 , and M 5 ) are selectively linked to G q/11 proteins, and the even-numbered subtypes (M 2 and M 4 ) are preferentially coupled to the pertussis toxin (PTX)-sensitive G i/o proteins (Felder, 1995; Wess, 1996; Caulfield and Birdsall, 1998) . The highest density of spinal mAChRs is located in the superficial laminae in both rats and humans (Yamamura et al., 1983; Scatton et al., 1984; Villiger and Faull, 1985; Hoglund and Baghdoyan, 1997; Li et al., 2002) . Previous studies have documented that M 2 , M 3 , and M 4 mAChR subtypes are present in the spinal dorsal horn and that the M 2 and M 3 subtypes are particularly concentrated in the superficial laminae (Hoglund and Baghdoyan, 1997; Duttaroy et al., 2002; Chen et al., 2005) . Although the role of the M 2 and M 4 subtypes in mAChR agonist-induced analgesia has been established (Ellis et al., 1999; Gomeza et al., 1999a; Duttaroy et al., 2002; Li et al., 2002) , the mechanisms by which each mAChR subtype contributes to the regulation of nociceptive transmission in the spinal cord are not clear.
The spinal lamina II neurons receive nociceptive inflow from primary afferent neurons
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JPET Fast Forward. Published on September 18, 2007 as DOI: 10.1124 at ASPET Journals on November 5, 2016 jpet.aspetjournals.org Downloaded from JPET #127795 5 and synaptic input from glutamatergic excitatory and GABAergic/glycinergic interneurons in rats and mice (Yoshimura and Nishi, 1995; Pan and Pan, 2004; Zhang et al., 2005; Wang et al., 2006; Zhang et al., 2006) . Glycine is an important inhibitory neurotransmitter in the spinal cord, and blockade of glycine receptors in the spinal cord leads to hypersensitivity of dorsal horn neurons and allodynia (Yaksh, 1989; Cronin et al., 2004) . Glycine-like immunoreactive axons, dendrites and cell bodies are present in the spinal superficial dorsal horn (Todd, 1990; Todd et al., 1996) .
In the rat spinal cord, the M 3 subtype is mainly responsible for muscarinic potentiation of synaptic glycine release (Wang et al., 2006) . However, because highly selective agonists and antagonists for specific mAChR subtypes are not available, the definitive function of the individual mAChR subtypes in the regulation of glycinergic input to spinal dorsal horn neurons have yet to be established. In the present study, we used mAChR subtype-knockout (KO) mice to determine the role of the M 2 , M 3 and M 4 subtypes in the control of glycinergic input to spinal lamina II neurons. This study provides unambiguous evidence about the specific function of these three mAChR subtypes in the control of glycinergic synaptic transmission in the spinal dorsal horn.
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Mouse genotyping was carried out by Southern blotting and polymerase chain reaction analysis of mouse-tail DNA, as described previously (Gomeza et al., 1999a; Gomeza et al., 1999b; Yamada et al., 2001; Duttaroy et al., 2002) (Hylden and Wilcox, 1980) . Animals were allowed This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on September 18, 2007 as DOI: 10.1124 at ASPET Journals on November 5, 2016 jpet.aspetjournals.org Downloaded from JPET #127795 7 to recover for 3 days in their home cage before the final electrophysiological experiments.
Spinal cord slice preparation. Mice were anesthetized with 2% isoflurane in O 2 and the lumbar segment of the spinal cord was rapidly removed through laminectomy. The mice were then killed by inhalation of 5% isoflurane. The spinal cord segment was immediately placed in an ice-cold sucrose artificial cerebrospinal fluid (aCSF) pre-saturated with 95% O 2 and 5% CO 2 .
The sucrose aCSF contained (in mM) sucrose, 234; KCl, 3.6; MgCl 2 , 1.2; CaCl 2 , 2.5; NaH 2 PO 4 , 1.2; glucose, 12.0; and NaHCO 3 , 25.0. The tissue was then placed in a shallow groove formed in a gelatin block and glued onto the stage of a vibratome (Technical Product International, St.
Louis, MO). Transverse spinal cord slices (350 µ m) were cut in the ice-cold sucrose aCSF and pre-incubated in Krebs solution oxygenated with 95% O 2 and 5% CO 2 at 34°C for at least 1 h before they were transferred to the recording chamber. The Krebs solution contained (in mM) NaCl, 117.0; KCl, 3.6; MgCl 2 , 1.2; CaCl 2 , 2.5; NaH 2 PO 4 , 1.2; glucose, 11.0; and NaHCO 3 , 25.0.
Each slice was placed in a glass-bottomed chamber (Warner Instruments, Hamden, CT) and fixed with parallel nylon threads supported by a U-shaped stainless steel weight. The slice was continuously perfused with Krebs solution at 5.0 ml/min at 34°C maintained by an inline solution heater and a temperature controller (TC-324, Warner Instruments).
Electrophysiological recordings.
Recordings of postsynaptic currents were performed using the whole-cell voltage-clamp method, as we described previously (Li et al., 2002; Zhang et al., 2005) . The lamina II has a distinct translucent appearance and can easily be distinguished under the microscope. The neurons located in the lamina II in the spinal slice were identified This article has not been copyedited and formatted. The final version may differ from this version. . GDP-β-S was added to the internal solution to block the possible postsynaptic effect mediated by mAChR agonists through G proteins (Li et al., 2002; Zhang et al., 2005) . QX314, a sodium channel blocker, was added to the internal solution to suppress the action potential generation from the recorded cell.
Recordings of postsynaptic currents began about 5 min after whole-cell access was established and the current reached a steady state. The input resistance was monitored, and the recording was abandoned if the resistance changed more than 15%. Signals were recorded using an amplifier (MultiClamp700A, Axon Instruments, Foster City, CA) at a holding potential of 0 mV, filtered at 1-2 kHz, digitized at 10 kHz, and stored in a Pentium computer with pCLAMP Measurements of the amplitude and frequency of sIPSCs and mIPSCs were performed for at least 2 min during control, drug application, and washout recovery. The sIPSCs and mIPSCs were detected by the fast rise time of the signal over an amplitude threshold above the background noise (Zhang et al., 2005; Zhang et al., 2006) . The amplitude detection threshold was typically 6-8 pA. We manually excluded an event when the noise was erroneously identified as sIPSCs or mIPSCs by the computer program. The background noise level was typically constant throughout the recording in a given neuron. The cumulative probabilities of the amplitude and inter-event interval of sIPSCs and mIPSCs were compared using the Komogorov-Smirnov test.
The effects of oxotremorine-M on the frequency and amplitude of sIPSCs and mIPSCs were determined using paired two-tailed Student's t-test or one-way analysis of variance. The Komogorov-Smirnov test was used to determine whether the drug effect on sIPSCs and mIPSCs was significantly different. P < 0.05 was considered statistically significant. (Fig. 2) . These data strongly suggest that activation of the M 2 and M 4 subtypes decreases inhibitory glycinergic input to spinal dorsal horn neurons.
We further determined the potential role the M 2 and M 4 subtypes in the inhibitory effect of the mAChR agonist on synaptic glycine release to spinal dorsal horn neurons in M 3 -KO mice.
In 14 other lamina II neurons from the M 3 -KO mice, the effect of 5 µ M oxotremorine-M on the frequency of sIPSCs was partially blocked by 10 µ M AFDX-116 (Fig. 3, A and B) , an M 2 receptor-preferring antagonist (Coelho et al., 2000; Douglas et al., 2001; Wang et al., 2006) . In 12 additional neurons from M 3 -KO mice, the effect of oxotremorine-M was completely blocked by 2 µ M himbacine (Fig. 3C) , an M 2 /M 4 -preferring antagonist (Dorje et al., 1991; Miller et al., 1992; Doller et al., 1999; Zhang et al., 2005) . These data provide further evidence that the M 2 and M 4 subtypes contribute to the inhibition of spinal glycine release by stimulation of mAChRs in mice.
Effect of oxotremorine-M on glycinergic sIPSCs and mIPSCs in M 2 /M 4 double-KO mice
To determine the role of the M 3 subtype in muscarinic regulation of synaptic glycine release to lamina II neurons, we examined the effect of oxotremorine-M on the glycinergic (Fig. 4, A-C) .
Synaptic GABA release is profoundly increased by oxotremorine-M because it stimulates the M 3 subtype expressed in GABAergic interneurons in M 2 /M 4 double-KO mice . Thus, the increased GABA release could spillover and activate presynaptic GABA B receptors on glycinergic neurons to inhibit glycine release. To test this hypothesis, we used the GABA B receptor antagonist CGP55845 (Li et al., 2002; Wang et al., 2006) . In the presence of 1 µ M CGP55845, oxotremorine-M significantly increased the frequency of sIPSCs in a concentration-dependent fashion in all 12 neurons studied (Fig. 4D) . These findings indicate that activation of the M 3 subtype contributes to muscarinic potentiation of spinal glycine release and that spinal glycine release by the M 3 subtype is influenced by concurrent M 3 receptor-mediated stimulation of GABAergic interneurons, which evokes spinal GABA release and activate presynaptic GABA B receptors on glycinergic interneurons to limit the further release of glycine.
It has been documented that M 2 , M 3 , and M 4 mAChR subtypes are present in the spinal dorsal horn (Hoglund and Baghdoyan, 1997; Duttaroy et al., 2002; Chen et al., 2005) . To confirm the role of the M 3 subtype in the potentiating effect of oxotremorine-M on synaptic glycine release in M 2 /M 4 double-KO mice, we further tested the effect of 5 µ M oxotremorine-M on glycinergic sIPSCs in the presence of 50 nM 4-DAMP, an M 3 subtype-preferring mAChR antagonist (Cembala et al., 1998; Moriya et al., 1999; Zhang et al., 2005) (Fig. 5B) . However, compared with the initial effect of oxotremorine-M on the sIPSCs, the effect of oxotremorine-M on the mIPSCs was significantly attenuated. These data suggest that the M 3 subtype is located on the presynaptic terminals and somatodendritic sites of glycinergic interneurons in the spinal cord.
Effect of oxotremorine-M on sIPSCs in PTX-treated WT mice
To further define the role of the M 3 subtype in the potentiating effect of oxotremorine-M on sIPSCs, a group of WT mice were treated intrathecally with 1 µ g of PTX to inactivate G i/o proteins that are coupled to M 2 /M 4 subtypes (Zhang et al., 2005) . In all 14 neurons from PTXtreated mice, oxotremorine-M consistently increased the frequency of sIPSCs in a dose-dependent manner (Fig. 6) (Fig. 7A ). Oxotremorine-M had no significant effect on the frequency of glycinergic sIPSCs in the remaining 13 neurons (40.6%).
To determine whether the lack of effect of oxotremorine-M on sIPSCs in lamina II neurons was due to the opposing effects of the M 3 and M 4 subtypes, we selected another 10 neurons in which the initial application of 5 µ M oxotremorine-M had no significant effect on sIPSCs. After bath perfusion of 100 nM MT-3 toxin, a selective M 4 subtype antagonist (Jolkkonen et al., 1994; Ellis et al., 1999) , oxotremorine-M significantly increased the frequency of glycinergic sIPSCs in all neurons tested (Fig. 7B) . These findings suggest that in the absence of the M 2 subtype, the M 3 subtype plays a major role in the control of spinal glycine release.
Furthermore, the effect of the M 3 subtype on glycinergic input was suppressed by the M 4 subtype in a population of dorsal horn neurons.
Effect of oxotremorine-M on sIPSCs in M 4 -KO mice
To assess the relative role of the M 2 and M 3 subtypes, we examined the effect of oxotremorine-M in M 4 -KO mice. CGP55845 (1 µ M) was also used to remove the influence of GABA B receptors on oxotremorine-M-induced glycine release. In 13 of 33 (39.4%) neurons from M 4 single-KO mice, oxotremorine-M dose dependently increased the frequency of sIPSCs (Fig.   8 ). In contrast, oxotremorine-M decreased the frequency of sIPSCs in another 13 (39.4%) neurons and had no effect on the frequency of sIPSCs in the remaining 7 (21.2%) neurons.
Together with the above results, these data suggest that in the absence of the M 4 subtype, the M 2 This article has not been copyedited and formatted. The final version may differ from this version. Despite the findings from our current study, the physiological function of the M 3 subtype in the control of spinal nociceptive transmission remains largely unknown. We found that in M 2 /M 4 double-KO mice, the overall effect of oxotremorine-M was to increase glycinergic sIPSCs.
Our observation that the M 3 subtype-preferring mAChR antagonist 4-DAMP (Cembala et al., 1998; Moriya et al., 1999; Zhang et al., 2005) abolished the potentiating effect of oxotremorine-M on sIPSCs in M 2 /M 4 double-KO mice provides further support for our conclusion that the M 3 subtype contributes to the potentiation of spinal glycine release. In M 2 /M 4 double-KO mice, oxotremorine-M significantly increased the frequency of mIPSCs, but significantly less than it increased the frequency of sIPSCs. Thus, the M 3 subtype is likely located on the presynaptic terminals as well as on somatodendritic sites of glycinergic interneurons in the mouse spinal cord.
We were surprised that the potentiating effect of oxotremorine-M on the frequency of sIPSCs was (to decrease glycine release) and the M 3 (to increase glycine release) subtypes in M 4 -KO mice.
We found that oxotremorine-M decreased the frequency of sIPSCs in about 40% of the neurons but increased the frequency of sIPSCs in approximately 40% of neurons and had no effect on sIPSCs in about 20% neurons in M 4 -KO mice. These data suggest that the M 2 and M 3 subtypes are equally important in the regulation of spinal glycine release. Thus, our findings provide important evidence that the three mAChR subtypes in the spinal cord contribute to a different extent (i.e., M 2 = M 3 > M 4 ) to the muscarinic modulation of glycinergic input to dorsal horn neurons.
Results from our previous studies using relatively selective mAChR antagonists suggested that the activation of mAChRs potentiates spinal glycine release in rats (Wang et al., 2006) . In the present study, however, stimulation of mAChRs primarily inhibited glycine release in the mouse spinal cord. Hence, there exist important species differences regarding the function and subcellular distribution of mAChR subtypes in the regulation of spinal glycine release. For example, activation of the M 2 subtype seems to increase spinal glycine release in rats (Wang et (Ellis et al., 1999; Gomeza et al., 1999a; Duttaroy et al., 2002; Li et al., 2002) . It is not yet clear how the reduction of glycine release by spinal M 2 and M 4 subtypes contributes to the analgesic effect of mAChR agonists in mice. Because the recorded lamina II neurons are likely interneurons, it is possible that reduced glycinergic input may lead to disinhibition of inhibitory neurons in spinal dorsal horn to reduce nociceptive transmission . Furthermore, glycine is a co-agonist for the glycine binding site of NMDA receptors. Decreased synaptic glycine release may reduce nociceptive transmission by decreasing NMDA receptor activity in the superficial dorsal horn.
In summary, our study using subtype selective KO mice provides unequivocal evidence that activation of the M 2 and M 4 mAChR subtypes inhibits glycine release and that activation of the M 3 subtype potentiates glycine release in the spinal dorsal horn of mice (Fig. 9) . Another interesting finding is that the GABA B receptor is involved in the regulation of spinal glycine release through activation of the M 3 subtype expressed on GABAergic interneurons (Fig. 9) . 
